ABD-3001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABD-3001, covering 2025-01-20 to 2025-01-20. Get the full timeline:
Most recent: Clinical Trial Update: First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients [Phase 1, Phase 2]